Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed Aug 18, 2023

Accession no.
0001209191-23-046474
Filed
Aug 18, 2023, 7:10 AM ET
Trade date
Aug 17, 2023
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 8 non-derivative transactions. Open-market purchases total $175.8K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 17, 2023Common StockPPurchaseAcquired+1,500$1.74+$2,602.5200,858,194Indirect
Aug 17, 2023Common StockPPurchaseAcquired+1,450$1.75+$2,530.25200,859,644Indirect
Aug 17, 2023Common StockPPurchaseAcquired+47,050$1.75+$82,337.5200,906,694Indirect
Aug 17, 2023Common StockPPurchaseAcquired+3,918$1.76+$6,876.09200,910,612Indirect
Aug 17, 2023Common StockPPurchaseAcquired+1,850$1.76+$3,251.38200,912,462Indirect
Aug 17, 2023Common StockPPurchaseAcquired+23,264$1.76+$40,944.64200,935,726Indirect
Aug 17, 2023Common StockPPurchaseAcquired+6,168$1.77+$10,917.36200,941,894Indirect
Aug 17, 2023Common StockPPurchaseAcquired+14,800$1.78+$26,344200,956,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)